Physician profile
Frank I Singleton
NPI 1447314372
$915.41
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $61.74 · 2024: $70.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $277.54 | 2019 | |
| Lilly USA, LLC | $220.63 | 2019 | |
| Pfizer INC. | $156.80 | 2019-2024 | |
| Stemline Therapeutics INC. | $58.75 | 2019 | |
| Rigel Pharmaceuticals, INC. | $58.75 | 2019 | |
| Intra-Sana Laboratories | $50.00 | 2024 | Reltone 400 Mg, Reltone 200 Mg |
| Janssen Biotech, INC. | $31.88 | 2020 | |
| Eusa Pharma (US) LLC | $29.86 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.52 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.